BM2L is a spontaneous leukemogenic variant of a non-leukemogenic v-myb-transformed myeloid cell line.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

BM2L is a spontaneous leukemogenic variant of a non-leukemogenic v-myb-transformed myeloid cell line.

Oncogene - 1 Mar 1993

Bottazzi M E, Goodenow M M, Moscovici M G, Moscovici C

Abstract excerpt

Leukemogenesis is a complex process involving an accumulation of genetic lesions affecting both growth and differentiation in cells of the hematopoietic lineage. Our laboratory has established a non-producer v-myb-transformed cell line (BM2/C3A) which, when injected into the chicken embryo, does...

Topics

Alleles
Animals
Base Sequence
Cell Adhesion
Cell Differentiation
Cell Line, Transformed
Cell Transformation, Neoplastic
Chick Embryo
Leukemia, Monocytic, Acute
Molecular Sequence Data
Oncogene Proteins v-myb
Oncogenes
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-myb
Retroviridae Proteins, Oncogenic

Source

Open in PubMed

Identifiers

PMID: 8437856

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8437856-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics